This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Senju Pharmaceutical Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Norihiko Takeda: Innovator in Pharmaceutical Chemistry
Introduction
Norihiko Takeda is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways.
Latest Patents
One of his notable patents is for an alkynyl indazole derivative, which is designed to inhibit VEGF receptor tyrosine kinase activity. This compound is particularly useful as an active ingredient for treating diseases associated with angiogenesis or edema, such as age-related macular degeneration. The patent includes a general formula for the alkynyl indazole derivative, its pharmaceutical acceptable salts, and formulations containing the compound.
Career Highlights
Norihiko Takeda is currently associated with Senju Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the development of new therapeutic agents. His work has been instrumental in advancing treatments for various medical conditions.
Collaborations
He has collaborated with notable colleagues, including Tomoyo Miyabe and Shinnosuke Machida, to further enhance the research and development efforts within his field.
Conclusion
Norihiko Takeda's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his role as a key figure in the advancement of medical treatments. His ongoing work promises to impact the future of therapeutic development significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile